Saltar al contenido principal

ETHNOS_APP

Inicio • Búsqueda • Revistas • Lista 0

Lubova Renemane

Datos Biográficos

ID7876432
NOMBRELubova Renemane
NOMBRESLubova
APELLIDORenemane
FIRMARENEMANE L
AFILIACIONESRiga Stradiņš University
ORCID0000-0002-3700-3905
VERIFICADOSí
TOTAL DE OBRAS4
TOTAL DE CITAS0
TOTAL COMO AUTOR4
TOTAL COMO EDITOR0
PRIMER AÑO DE PUBLICACIÓN2022
AÑO MÁS RECIENTE DE PUBLICACIÓN2025
ÍNDICE H0
  • Psychoactive Substance Use and Its Association with Mental Health Symptomatology Among Latvian Medical Students

    Open Access•Warnakulasuriya S A V Fernando, A Hinds David et al.•ARTICLE•International Journal of…•2025

    Medical students are at elevated risk for psychoactive substance use and mental health challenges due to academic pressures and environmental stressors. This study aimed to determine the prevalence and trends of psychoactive substance use among medical students at Riga Stradins University (RSU) and to examine associations with symptoms of anxiety, depression, and resilience to stress. A bilingual, anonymous cross-sectional study was conducted usi…

  • Sertraline induced acute hepatocellular liver injury in patient with major depressive disorder

    Open Access•Lubova Renemane, Elmārs Rancāns•ARTICLE•Frontiers in Psychiatry•2024

    This case report describes a patient with major depressive disorder (MDD) who developed acute hepatocellular liver injury after being treated with sertraline, a selective serotonin reuptake inhibitor (SSRI). The diagnosis of MDD was made two years prior, and the patient had previously responded partially to escitalopram and cognitive-behavioral therapy (CBT). Upon switching to sertraline 50 mg daily, the patient presented with severe symptoms ind…

  • Case report

    Open Access•Lubova Renemane, Elmārs Rancāns•ARTICLE•Frontiers in Psychiatry•2023

    The present case report describes a patient with treatment-resistant schizophrenia and auto-aggressive compulsive behavior who was effectively treated with a third-generation antipsychotic medication, cariprazine. The diagnosis was made 12 years ago, and the patient has been hospitalized 14 times and undergone various antipsychotic treatments. Despite receiving both inpatient and outpatient care, the patient's response to treatment has been only …

  • Validation of the generalized anxiety disorder scales (GAD-7 and GAD-2) in primary care settings in Latvia

    Open Access•Jeļena Vrubļevska, Lubova Renemane et al.•ARTICLE•Frontiers in Psychiatry•2022

    This is the first study to report criterion validity of the Latvian and Russian (for Latvia) versions of the GAD-7 and GAD-2, assessed in a nationwide study conducted at the primary care level

Sin obras prominentes en esta página.

  • Validation of the generalized anxiety disorder scales (GAD-7 and GAD-2) in primary care settings in Latvia

    Open Access•Jeļena Vrubļevska, Lubova Renemane et al.•ARTICLE•Frontiers in Psychiatry•2022

    This is the first study to report criterion validity of the Latvian and Russian (for Latvia) versions of the GAD-7 and GAD-2, assessed in a nationwide study conducted at the primary care level

  • Case report

    Open Access•Lubova Renemane, Elmārs Rancāns•ARTICLE•Frontiers in Psychiatry•2023

    The present case report describes a patient with treatment-resistant schizophrenia and auto-aggressive compulsive behavior who was effectively treated with a third-generation antipsychotic medication, cariprazine. The diagnosis was made 12 years ago, and the patient has been hospitalized 14 times and undergone various antipsychotic treatments. Despite receiving both inpatient and outpatient care, the patient's response to treatment has been only …

  • Sertraline induced acute hepatocellular liver injury in patient with major depressive disorder

    Open Access•Lubova Renemane, Elmārs Rancāns•ARTICLE•Frontiers in Psychiatry•2024

    This case report describes a patient with major depressive disorder (MDD) who developed acute hepatocellular liver injury after being treated with sertraline, a selective serotonin reuptake inhibitor (SSRI). The diagnosis of MDD was made two years prior, and the patient had previously responded partially to escitalopram and cognitive-behavioral therapy (CBT). Upon switching to sertraline 50 mg daily, the patient presented with severe symptoms ind…

  • Psychoactive Substance Use and Its Association with Mental Health Symptomatology Among Latvian Medical Students

    Open Access•Warnakulasuriya S A V Fernando, A Hinds David et al.•ARTICLE•International Journal of…•2025

    Medical students are at elevated risk for psychoactive substance use and mental health challenges due to academic pressures and environmental stressors. This study aimed to determine the prevalence and trends of psychoactive substance use among medical students at Riga Stradins University (RSU) and to examine associations with symptoms of anxiety, depression, and resilience to stress. A bilingual, anonymous cross-sectional study was conducted usi…

Anxiety (3 obras) · Medicine (3 obras) · Psychiatry (3 obras) · Psychology (2 obras) · Adverse effect (1 obras) · Antidepressant (1 obras) · Antipsychotic (1 obras) · Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (1 obras) · Cannabis (1 obras) · Child and Adolescent Psychosocial and Emotional Development (1 obras)

Ethnos_APP • Proyecto Open Source • Licencia MIT • Frontend v2.0.0 • Privacidad y Cookies • Documentación de la API: api.ethnos.app/docs • Código de la API: GitHub • DOI: 10.5281/zenodo.17049435 • Código del Frontend: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae